CMS yesterday updated its FAQ for state Medicaid and Children’s Health Insurance Program agencies, answering questions related to flexibilities related to managed care, benefits, financing, Section 1115 demonstrations, and Section 1135 waivers offered as part of the president’s declaration of a national emergency. 

The agency also clarified coverage of COVID-19 diagnosis and treatment by catastrophic health plans. The document aligns with guidance released last week by the Internal Revenue Service, which gave high deductible health plans flexibility to provide COVID-19 diagnosis and treatment benefits without deductibles or cost-sharing.

Related News Articles

Headline
The Food and Drug Administration today authorized a single Pfizer COVID-19 booster dose for children aged 5-11 who completed the Pfizer vaccine primary series…
Headline
A recent op-ed in the online publication STAT contains “blatant factual inaccuracies” and omits critical information about hospital and health systems’…
Blog
A recent op-ed in the online publication STAT (Turn off the spigot for hospitals’ COVID-19 relief funding) contains blatant factual inaccuracies but also omits…
Headline
The Health Resources and Services Administration has extended to May 18 the deadline for health care providers who received Provider Relief Fund payments…
Perspective
Yesterday, our country surpassed a grim and somber milestone: 1 million COVID-19 deaths in the U.S.. America’s hospitals and health systems — and their…
Headline
As U.S. COVID-19 deaths today surpassed 1 million, the AHA, American Medical Association, and American Nurses Association continued to urge everyone who is…